Brian Piekos's Net Worth
$804 Thousand
Who is Brian Piekos?
Brian Piekos does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Gemini Therapeutics, Inc. /DE, AMAG PHARMACEUTICALS, INC., and Elicio Therapeutics, Inc..
SEC CIK
Brian Piekos's CIK is 0001815308
Past Insider Trading and Trends
2021 was Brian Piekos's most active year for acquiring shares with 3 total transactions. Brian Piekos's most active month to acquire stocks was the month of April. 2020 was Brian Piekos's most active year for disposing of shares, totalling 2 transactions. Brian Piekos's most active month to dispose stocks was the month of October. 2021 saw Brian Piekos paying a total of $72,431.61 for 476,109 shares, this is the most they've acquired in one year. In 2020 Brian Piekos cashed out on 41,038 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Gemini Therapeutics, Inc. /DE (IRON) Snapshot price: $50.35
CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +130.11% | 9.96K |
$1.09 | $10,856.40 | 17.61K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 18
| |||
Form 4
|
∞
| 7.66K |
$9.46 | $72,431.61 | 7.66K |
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMAG PHARMACEUTICALS, INC. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -31.54K |
—
|
—
|
0
|
Nov 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Elicio Therapeutics, Inc. (ELTX) Snapshot price: $3.96
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
KalVista Pharmaceuticals, Inc. (KALV) No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||